Jefferies Financial Group Inc. decreased its position in CVS Health Corporation (NYSE:CVS – Free Report) by 80.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 7,814 shares of the pharmacy operator’s stock after selling 33,203 shares during the period. Jefferies Financial Group Inc.’s holdings in CVS Health were worth $670,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Elevation Wealth Partners LLC increased its holdings in CVS Health by 41.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 105 shares in the last quarter. HBW Advisory Services LLC raised its stake in CVS Health by 3.5% in the 3rd quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator’s stock valued at $292,000 after purchasing an additional 115 shares during the last quarter. Apella Capital LLC raised its position in shares of CVS Health by 1.7% in the second quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock valued at $724,000 after buying an additional 117 shares during the last quarter. Wellington Altus USA Inc. boosted its holdings in shares of CVS Health by 13.3% during the second quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after purchasing an additional 120 shares during the last quarter. Finally, Childress Capital Advisors LLC grew its holdings in CVS Health by 3.9% in the 3rd quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator’s stock valued at $300,000 after buying an additional 131 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.
Key Stories Impacting CVS Health
These are some of the CVS stories that stood out recently:
- Positive Sentiment: A separation could give the pharmacy business and CVS’s other operations sharper strategic focus and improve capital allocation. Some analysts see potential for the pieces to be worth more separately, though the plan is not expected until 2028. CVS Breakup Won’t Satisfy Washington. It Could Still Work for Wall Street.
- Positive Sentiment: CVS’s recent quarterly results were strong: earnings of $2.09 per share exceeded the $1.65 consensus estimate, while revenue also topped expectations. CVS Beat Earnings by 27% and Split in Two
- Negative Sentiment: Carving out the retail pharmacies could involve significant execution costs and operational risks, leaving uncertainty about whether the restructuring will deliver the anticipated value. Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
Insider Buying and Selling
In other news, EVP Prem Shah bought 23,855 shares of CVS Health stock in a transaction on Friday, November 6th. The shares were bought at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the acquisition, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This represents a 36.89% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.85% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of research analysts have weighed in on CVS shares. Argus lifted their price target on shares of CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, November 9th. Piper Sandler set a $106.00 price objective on CVS Health in a research note on Friday. Barclays lowered their price target on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a report on Thursday, November 5th. Finally, TD Cowen reiterated a “buy” rating on shares of CVS Health in a report on Wednesday, November 4th. Twenty-three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $107.54.
View Our Latest Research Report on CVS
CVS Health Price Performance
CVS opened at $89.37 on Monday. The company has a market capitalization of $114.34 billion, a P/E ratio of 10.40, a PEG ratio of 0.78 and a beta of 0.58. The company has a 50-day moving average of $89.65 and a 200-day moving average of $89.09. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping the consensus estimate of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.60 earnings per share. Equities analysts expect that CVS Health Corporation will post 8.26 EPS for the current fiscal year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is currently 30.97%.
About CVS Health
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Featured Articles
- Five stocks we like better than CVS Health
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
